Jin Yan Jin Selected Research

lebrikizumab

10/2017

Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin Yan Jin Research Topics

Disease

4	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2020 - 01/2017
4	Breast Neoplasms (Breast Cancer) 01/2019 - 08/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2020 - 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Inflammation (Inflammations) 10/2017
1	Airway Obstruction (Choking) 10/2017
1	Asthma (Bronchial Asthma) 10/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017
1	Neoplasms (Cancer) 04/2011

Drug/Important Bio-Agent (IBA)

4	polatuzumab vedotinIBA 12/2020 - 01/2020
4	Ado-Trastuzumab EmtansineIBA 01/2019 - 08/2014
3	human ERBB2 proteinIBA 01/2019 - 01/2017
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 08/2014
2	Biomarkers (Surrogate Marker)IBA 10/2017 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 08/2014
1	Rituximab (Mabthera)FDA Link 12/2020
1	Bendamustine Hydrochloride FDA Link 12/2020
1	monomethyl auristatin EIBA 01/2020
1	pertuzumabIBA 01/2019
1	ipatasertibIBA 01/2019
1	lebrikizumabIBA 10/2017
1	Interleukin-13IBA 10/2017
1	Monoclonal AntibodiesIBA 10/2017
1	HhAntag691IBA 04/2011
1	Glycoproteins (Glycoprotein)IBA 04/2011

Therapy/Procedure

1	Castration 01/2019
1	Therapeutics 12/2017